Cardiologists enthuse over Cordis' sirolimus trial results
This article was originally published in Clinica
Final results of the pivotal US study for Cordis' sirolimus-eluting stent show that the device not only reduces the re-blockage of coronary arteries but ensures that a wide variety of at-risk patients can avoid the need to undergo future revascularisation.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.